Search results (209)
« Back to PublicationsReactive astrocytes mediate toxicity in iPSC derived dopaminergic neurons.
Ibarra-Aizpurua N. et al, (2026), NPJ Parkinsons Dis
SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides.
Loreto A. et al, (2025), Neurobiol Dis, 213
Recent developments in gene therapy for Parkinson's disease.
Szunyogh S. et al, (2025), Mol Ther, 33, 2052 - 2064
Tau depletion in human neurons mitigates Aβ-driven toxicity.
Ng B. et al, (2024), Mol Psychiatry, 29, 2009 - 2020
A fluid-walled microfluidic platform for human neuron microcircuits and directed axotomy.
Nebuloni F. et al, (2024), Lab Chip, 24, 3252 - 3264
Early deficits in an in vitro striatal microcircuit model carrying the Parkinson's GBA-N370S mutation.
Do QB. et al, (2024), NPJ Parkinsons Dis, 10
Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease.
Kilfeather P. et al, (2024), Cell Rep, 43
Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons
WADE-MARTINS R., (2023), Molecular Neurodegeneration, 18
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s
BRIMBLECOMBE K. et al, (2023), European Journal of Neuroscience
A fluid-walled microfluidic platform for human neuron microcircuits and directed axotomy
Nebuloni F. et al, (2023)
Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application.
Maheshwari S. et al, (2023), Transl Neurodegener, 12
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9
Vahsen B. et al, (2023), Nature Communications
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models.
Williamson MG. et al, (2023), Hum Mol Genet, 32, 2808 - 2821